Company Filing History:
1 out of 832,843 Years Active: 2002
Title: Tim Reudelhuber: Innovator in Pro-Protein Converting Enzyme Technology
Introduction
Tim Reudelhuber is an accomplished inventor based in Baie d'Urfé, Canada. He is known for his significant contribution to the field of biochemistry through his innovative patent related to pro-protein converting enzymes. With a keen interest in the mechanisms that govern protein activation, Reudelhuber has demonstrated his commitment to advancing medical science.
Latest Patents
Tim Reudelhuber holds one notable patent: the development of a method involving pro-protein converting enzyme 5 (PC5). This invention involves the cloning of human PC5 cDNA isolated from human adrenal gland messenger RNA. Furthermore, his innovation outlines a method for reducing restenosis at injured vascular sites by delivering an antisense nucleic acid that suppresses the expression of human PC5. This groundbreaking work has the potential to impact vascular health significantly.
Career Highlights
Reudelhuber's career is marked by significant achievements in the field of biotechnology. His research has paved the way for further studies involving pro-protein converting enzymes and their role in various medical conditions. With extensive knowledge in molecular biology, he has emerged as a key figure in the development of therapeutic strategies targeting cardiovascular issues.
Collaborations
Throughout his career, Tim Reudelhuber has collaborated with esteemed colleagues, including Robert Day and Nabil G Seidah. These partnerships have fostered a collaborative environment that encourages innovation and has led to advancements in their respective fields. Together, they have worked on various projects that explore the implications of pro-protein converting enzymes in health and disease.
Conclusion
Tim Reudelhuber is a vital contributor to the field of biochemistry, with his patent on pro-protein converting enzymes exemplifying his innovative spirit. His work holds promise for improving treatment options for conditions associated with vascular health. As he continues to collaborate with fellow researchers, Reudelhuber's contributions will likely influence future advancements in biotechnology.